BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,762,073 | +8.9% | 16,774,304 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $109,089,750 | -11.8% | 15,495,703 | +4.5% | 0.00% | -25.0% |
| Q1 2023 | $123,638,815 | -27.8% | 14,824,798 | -0.6% | 0.00% | -20.0% |
| Q4 2022 | $171,269,603 | -1.3% | 14,918,955 | +8.3% | 0.01% | -16.7% |
| Q3 2022 | $173,565,000 | +17.3% | 13,774,995 | -1.5% | 0.01% | +20.0% |
| Q2 2022 | $147,984,000 | -35.5% | 13,987,418 | -0.8% | 0.01% | -16.7% |
| Q1 2022 | $229,298,000 | +12.0% | 14,101,975 | -4.6% | 0.01% | +20.0% |
| Q4 2021 | $204,805,000 | -7.0% | 14,787,395 | -3.5% | 0.01% | -16.7% |
| Q3 2021 | $220,303,000 | -10.0% | 15,330,858 | -1.0% | 0.01% | -14.3% |
| Q2 2021 | $244,759,000 | +48.2% | 15,481,327 | -4.7% | 0.01% | +40.0% |
| Q1 2021 | $165,180,000 | +36.4% | 16,241,775 | -0.1% | 0.01% | +25.0% |
| Q4 2020 | $121,134,000 | +121.2% | 16,259,745 | +2.0% | 0.00% | +100.0% |
| Q3 2020 | $54,766,000 | -21.6% | 15,943,893 | +8.7% | 0.00% | -33.3% |
| Q2 2020 | $69,887,000 | +160.9% | 14,666,914 | +9.5% | 0.00% | +200.0% |
| Q1 2020 | $26,790,000 | -36.1% | 13,395,617 | +10.3% | 0.00% | -50.0% |
| Q4 2019 | $41,918,000 | +52.5% | 12,150,211 | +26.6% | 0.00% | +100.0% |
| Q3 2019 | $27,489,000 | -18.7% | 9,594,780 | +7.5% | 0.00% | 0.0% |
| Q2 2019 | $33,831,000 | -52.2% | 8,925,891 | +2.6% | 0.00% | -66.7% |
| Q1 2019 | $70,796,000 | -0.9% | 8,697,366 | -1.7% | 0.00% | -25.0% |
| Q4 2018 | $71,413,000 | +6.7% | 8,849,427 | +0.9% | 0.00% | +33.3% |
| Q3 2018 | $66,914,000 | +50.6% | 8,769,856 | +13.1% | 0.00% | +50.0% |
| Q2 2018 | $44,442,000 | +24.7% | 7,755,951 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $35,653,000 | -4.6% | 7,474,419 | -1.8% | 0.00% | 0.0% |
| Q4 2017 | $37,386,000 | +7.8% | 7,614,280 | +15.0% | 0.00% | 0.0% |
| Q3 2017 | $34,696,000 | -0.3% | 6,621,180 | +5.8% | 0.00% | 0.0% |
| Q2 2017 | $34,796,000 | -31.1% | 6,258,377 | +4.1% | 0.00% | -33.3% |
| Q1 2017 | $50,520,000 | +77623.1% | 6,014,277 | +58823.1% | 0.00% | – |
| Q4 2016 | $65,000 | +47.7% | 10,207 | +2.3% | 0.00% | – |
| Q3 2016 | $44,000 | -8.3% | 9,976 | -40.2% | 0.00% | – |
| Q2 2016 | $48,000 | +242.9% | 16,675 | +248.0% | 0.00% | – |
| Q1 2016 | $14,000 | -33.3% | 4,792 | +136.9% | 0.00% | – |
| Q4 2015 | $21,000 | +23.5% | 2,023 | +37.4% | 0.00% | – |
| Q3 2015 | $17,000 | -98.1% | 1,472 | -97.6% | 0.00% | -100.0% |
| Q2 2015 | $900,000 | +56.5% | 60,272 | -5.3% | 0.00% | 0.0% |
| Q1 2015 | $575,000 | -25.7% | 63,617 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $774,000 | +24.4% | 63,617 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $622,000 | -28.2% | 63,617 | -6.3% | 0.00% | 0.0% |
| Q2 2014 | $866,000 | – | 67,917 | +485021.4% | 0.00% | – |
| Q1 2014 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |